Novartis AG will cut as many as 8,000 jobs under a plan to save at least $1 billion by 2024 and boost the pharmaceutical giant’s performance.
The Swiss company detailed the cuts, equal to more than 7% of its global workforce, on Tuesday after outlining the restructuring in April. Among other things, Novartis plans to generate savings by combining its pharmaceuticals and oncology units.
